146 related articles for article (PubMed ID: 24984876)
1. Mitogen-activated protein kinases pathways mediate the sunitinib-induced hypertrophy in rat cardiomyocyte H9c2 cells.
Korashy HM; Al-Suwayeh HA; Maayah ZH; Ansari MA; Ahmad SF; Bakheet SA
Cardiovasc Toxicol; 2015 Jan; 15(1):41-51. PubMed ID: 24984876
[TBL] [Abstract][Full Text] [Related]
2. The role of aryl hydrocarbon receptor signaling pathway in cardiotoxicity of acute lead intoxication in vivo and in vitro rat model.
Ansari MA; Maayah ZH; Bakheet SA; El-Kadi AO; Korashy HM
Toxicology; 2013 Apr; 306():40-9. PubMed ID: 23391631
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of cardiotoxicity of gefitinib in vivo and in vitro rat cardiomyocyte: Role of apoptosis and oxidative stress.
Korashy HM; Attafi IM; Ansari MA; Assiri MA; Belali OM; Ahmad SF; Al-Alallah IA; Anazi FE; Alhaider AA
Toxicol Lett; 2016 Jun; 252():50-61. PubMed ID: 27084042
[TBL] [Abstract][Full Text] [Related]
4. Dasatinib induces gene expression of CYP1A1, CYP1B1, and cardiac hypertrophy markers (BNP, β-MHC) in rat cardiomyocyte H9c2 cells.
Alsaad AMS
Toxicol Mech Methods; 2018 Nov; 28(9):678-684. PubMed ID: 29975149
[TBL] [Abstract][Full Text] [Related]
5. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
6. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy.
Cheng TH; Shih NL; Chen CH; Lin H; Liu JC; Chao HH; Liou JY; Chen YL; Tsai HW; Chen YS; Cheng CF; Chen JJ
J Biomed Sci; 2005; 12(1):123-33. PubMed ID: 15864745
[TBL] [Abstract][Full Text] [Related]
7. Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-κB and MAPK signaling pathways.
Abdelhamid G; El-Kadi AO
Free Radic Biol Med; 2015 May; 82():1-12. PubMed ID: 25614461
[TBL] [Abstract][Full Text] [Related]
8. Development of cardiac hypertrophy by sunitinib in vivo and in vitro rat cardiomyocytes is influenced by the aryl hydrocarbon receptor signaling pathway.
Maayah ZH; Ansari MA; El Gendy MA; Al-Arifi MN; Korashy HM
Arch Toxicol; 2014 Mar; 88(3):725-38. PubMed ID: 24247421
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
10. 5-, 12- and 15-Hydroxyeicosatetraenoic acids induce cellular hypertrophy in the human ventricular cardiomyocyte, RL-14 cell line, through MAPK- and NF-κB-dependent mechanism.
Maayah ZH; El-Kadi AO
Arch Toxicol; 2016 Feb; 90(2):359-73. PubMed ID: 25600587
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells.
Kuo SC; Li Y; Cheng YZ; Lee WJ; Cheng JT; Cheng KC
Mol Med Rep; 2018 Nov; 18(5):4700-4708. PubMed ID: 30221729
[TBL] [Abstract][Full Text] [Related]
12. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
[TBL] [Abstract][Full Text] [Related]
13. Porphyromonas gingivalis-induced cellular hypertrophy and MMP-9 activity via different signaling pathways in H9c2 cardiomyoblast cells.
Lee SD; Wu CC; Chang YC; Chang SH; Wu CH; Wu JP; Hwang JM; Kuo WW; Liu JY; Huang CY
J Periodontol; 2006 Apr; 77(4):684-91. PubMed ID: 16584351
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury.
Yu D; Li M; Tian Y; Liu J; Shang J
Life Sci; 2015 Feb; 122():15-25. PubMed ID: 25476833
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase in endothelin-1-induced cardiac differentiation of mouse embryonic stem cells.
Chen M; Lin YQ; Xie SL; Wang JF
J Cell Biochem; 2010 Dec; 111(6):1619-28. PubMed ID: 21053276
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
[TBL] [Abstract][Full Text] [Related]
18. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
[TBL] [Abstract][Full Text] [Related]
19. Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.
Chen Y; Yao F; Chen S; Huang H; Wu L; He J; Dong Y
Pharmazie; 2014 Nov; 69(11):833-7. PubMed ID: 25985580
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes.
Tomaru Ki K; Arai M; Yokoyama T; Aihara Y; Sekiguchi Ki K; Tanaka T; Nagai R; Kurabayashi M
J Mol Cell Cardiol; 2002 Jun; 34(6):649-59. PubMed ID: 12054852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]